Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
- Posted on April 22, 2026
- By Bing News
- 0 Views
- 1 min read
Actuate Therapeutics drug improves survival odds in pancreatic cancer trial
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays.) By Nancy Lapid April 22 (Reuters) - Twice as many advanced pancreas cancer patients who received an experimental drug developed by Actuate Therapeutics with chemotherapy were alive after one year as those treated with chemo alone, according to results of a mid-stage trial. At
